Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
21 hedge funds and large institutions have $3.36M invested in Vaccinex, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
4% more call options, than puts
Call options by funds: $486K | Put options by funds: $466K
13% less funds holding
Funds holding: 24 → 21 (-3)
26% less capital invested
Capital invested by funds: $4.54M → $3.36M (-$1.18M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Natixis
Paris,
France
|
+$75.8K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$57.4K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$53.9K |
| 4 |
TI
Telemetry Investments
New York
|
+$29.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.99K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$136K |
| 2 |
VF
Virtu Financial
New York
|
-$106K |
| 3 |
Goldman Sachs
New York
|
-$60K |
| 4 |
IFWM
Institute for Wealth Management
Denver,
Colorado
|
-$56K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$36.9K |
VCNX Hedge Fund Activity: Q3 2021 in Review
21 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q3 2021, worth a combined $3.36M — down 26% from $4.54M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of VCNX and 3 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was Natixis, opening a new position worth an estimated $75.8K. The largest seller was Susquehanna International Group, cutting an estimated $136K.
- 21 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q3 2021, down from 24 in Q2 2021.
- Funds reported $3.36M of Vaccinex, Inc. Common Stock stock for Q3 2021, down 26% quarter-over-quarter.
- 3 funds opened new Vaccinex, Inc. Common Stock positions in Q3 2021 and 6 closed out, a net change of -3 holders.
- The largest Vaccinex, Inc. Common Stock buyer in Q3 2021 was Natixis, an estimated $75.8K added.
- The largest Vaccinex, Inc. Common Stock seller in Q3 2021 was Susquehanna International Group, an estimated $136K sold.
Based on aggregated 13F filings for Q3 2021.